Gonadotropin-releasing hormone agonists (GnRH-a) are common treatment options for central precocious puberty (CPP) in childhood. GnRH-a treatment is useful and has a good safety profile, with minimal adverse effects and no severe long-term consequences. The common side effects in children are menopause-like symptoms and local adverse events at the injection site.

Does the risk of arterial hypertension increase in the course of triptorelin treatment?

Palma, Laura
Writing – Original Draft Preparation
;
Gaudino, Rossella;Cavarzere, Paolo;Antoniazzi, Franco
2020-01-01

Abstract

Gonadotropin-releasing hormone agonists (GnRH-a) are common treatment options for central precocious puberty (CPP) in childhood. GnRH-a treatment is useful and has a good safety profile, with minimal adverse effects and no severe long-term consequences. The common side effects in children are menopause-like symptoms and local adverse events at the injection site.
GnRH-a; arterial hypertension; precocious puberty
File in questo prodotto:
File Dimensione Formato  
2019 Palma PP.pdf

non disponibili

Descrizione: articolo in fase di stampa
Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 94.85 kB
Formato Adobe PDF
94.85 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/997795
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact